However, no significant differences were observed between the patients with and those without HCC recurrence in terms of endostatin level before, early after, or late after LDLT (2.23 ± 2.68 vs. 3.07 ± 1.45 ng/mL, P = 0.210; 2.23 ± 2.35 vs. 3.06 ± 1.47 ng/mL, P = 0.108; 6.69 ± 4.76 vs. 4.50 ± 3.01 ng/mL, P = 0.293, respectively) or in VEGF late after LDLT (229.70 ± 85.28 vs. 418.52 ± 378.24 pg/mL, P = 0.503) (Figs 1–5). Here, VEGFA is linked to hepatocellular carcinoma.